Arrowhead Pharmaceuticals (ARWR) Total Debt Growth (1y) (2011 - 2026)
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 12.42% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 3.78% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.00% |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - | -7.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.88% |
| Mar 31, 2026 | -27.12% |
| Dec 31, 2025 | -50.39% |
| Sep 30, 2025 | -35.17% |
| Sep 30, 2019 | 16.13% |
| Jun 30, 2019 | 13.52% |
| Mar 31, 2019 | 11.06% |
| Dec 31, 2018 | -7.36% |
| Sep 30, 2018 | -23.02% |
| Jun 30, 2018 | -7.93% |
| Mar 31, 2018 | -7.65% |
| Dec 31, 2017 | -7.38% |
| Sep 30, 2017 | -26.98% |
| Jun 30, 2017 | -29.26% |
| Mar 31, 2017 | 175.58% |
| Dec 31, 2016 | 102.28% |
| Sep 30, 2016 | 217.77% |
| Jun 30, 2016 | 111.77% |
| Mar 31, 2016 | -41.03% |
| Dec 31, 2015 | -25.99% |